-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Betrixaban is an anticoagulant drug that belongs to the class of direct oral anticoagulants (DOACs).
It is used for the prevention and treatment of thromboembolic events, such as deep vein thrombosis and pulmonary embolism.
The production process of betrixaban involves several steps, which are explained below.
- Extraction of the Active Ingredient: The active ingredient of betrixaban is extracted from a type of Japanese seaweed called Sargassum thunbergii.
The seaweed is collected and dried, and then the active ingredient is extracted using a combination of water and organic solvents. - Purification of the Active Ingredient: The extracted active ingredient is purified using a series of chromatography techniques.
The first step involves the use of a gel permeation chromatography (GPC) column to separate the impurities from the active ingredient.
The pure active ingredient is then further purified using high-performance liquid chromatography (HPLC). - Synthesis of the Chemical Intermediates: The purified active ingredient is then used as a starting material to synthesize the chemical intermediates required for the production of betrixaban.
The synthesis of the intermediates involves a series of chemical reactions, including esterification, hydrolysis, and condensation reactions. - Synthesis of Betrixaban: The chemical intermediates are then used to synthesize betrixaban.
This involves the use of a series of chemical reactions, including condensation, oxidation, and reduction reactions. - Purification of Betrixaban: After the synthesis of betrixaban, it is purified using a series of chromatography techniques, including HPLC and gel filtration chromatography (GFC).
This step ensures that the final product is free of impurities and meets the required purity standards. - Formulation: After the purification of betrixaban, it is formulated into the required dosage forms, such as tablets, capsules, or suspensions.
This step involves the use of excipients, such as fillers, binders, and coatings, to ensure stability and bioavailability of the drug. - Packaging and Distribution: The final product is then packaged into the required containers and distributed to pharmacies and hospitals.
In conclusion, the production process of betrixaban involves several steps, including the extraction of the active ingredient, purification of the active ingredient, synthesis of chemical intermediates, synthesis of betrixaban, purification of betrixaban, formulation, and packaging and distribution.
Each step must be carried out carefully and meticulously to ensure that the final product meets the required quality standards and is safe for use by patients.